FDA approves KemPharm's opioid painkiller

From Reuters - February 23, 2018

(Reuters) - KemPharm Inc said on Friday the U.S. Food and Drug Administration approved its opioid painkiller Apadaz for the short-term management of acute pain.

The company resubmitted the drugs marketing application for review in September last year after appealing against the drug regulators decision to reject it in 2016.

The FDA had said intranasal abuse of the opioid-based product was a relevant concern.


Continue reading at Reuters »